Actinic Keratoses
4
Pipeline Programs
4
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
1
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
AP
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Pierre Fabre5-fluorouracil 4%
Rigel Pharmaceuticalsimiquimod 5% cream
Amryt PharmaOleogel-S10 100 mg/g
ME TherapeuticsAVX001
Clinical Trials (4)
Total enrollment: 311 patients across 4 trials
Frequency and Intensity of Local Reactions in Patients Treated With 4% 5-FU vs 4% 5-FU Associated With an Emollient Cream: a Randomised, Controlled Clinical Trial
Start: Feb 2021Est. completion: Jan 2022146 patients
Phase 4Completed
Topical Imiquimod Cream in Combination With Cryotherapy for the Treatment of Actinic Keratoses
Start: Oct 2008Est. completion: Mar 2010
Phase 4Completed
The Efficacy and Tolerability of Oleogel-S-10 in Patients With Actinic Keratoses
Start: Oct 2008Est. completion: Nov 2010165 patients
Phase 2Completed
Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Start: Nov 2021Est. completion: Mar 2022
Phase 1/2Unknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space